For Clinicians For Investors Careers Search
Skelesound Request a briefing
Vibroacoustic Therapy Systems

We write the physical code that cells are built to read.

Skelesound builds whole-body platforms that turn water into programmable mechanical force — a new category of precision mechanotherapy.

01 · CLINICIANS
The science & evidence
Mechanism of action, safety architecture, and the investigational program.
02 · INVESTORS
The opportunity
A defensible platform across large indication landscapes. Request the briefing.
03 · PARTNERS
Collaborate with us
Research sites, health systems, and strategic development partners.
The Platform

Three mechanical fields, delivered at once.

Not vibration, not a bath — a mechanical field generator that couples force to the whole body through water, from the skin down to the cytoskeleton.

MACRO
The Whirlpool
Rotational fluid shear strips the boundary layer off the skin. 72 exciters, 18–30 Hz.
MESO
Interference Lattice
144 phased ultrasound transducers form a moving 3D grid of pressure nodes.
MICRO
Cellular Microstrain
0.5–0.85 MHz deforms the membrane to trigger direct integrin activation.
Products

One platform, two form factors.

FLAGSHIP · WHOLE-BODY
SkeleDrum MK-IV
Whole-body immersion reactor — 300 gallons, 100% surface coupling, closed-loop tuning.
Product overview
FOCUSED · EXTREMITY
SonoLimb
Focused limb recovery at 3× energy density — clinic-ready, sealed, portable.
Product overview
The Science

Physical force becomes gene expression.

Force on the extracellular matrix flexes integrins, fires focal adhesion kinase, and translocates YAP/TAZ to the nucleus — the mechanotransduction cascade Skelesound is designed to drive.

FORCE INTEGRIN · FAK CYTOSKELETON YAP/TAZ → DNA
Read the mechanism of action
Newsroom

Latest from Skelesound.

All news
image
COMPANY · MAR 2026
Skelesound closes Series A to advance the SkeleDrum platform
image
SCIENCE · FEB 2026
Preclinical data on fractal signaling and integrin density
image
REGULATORY · JAN 2026
Pre-submission meeting requested with the FDA

Partner with us on the next language of medicine.

Investors, clinicians, and strategic partners — request a confidential briefing.

Request a briefing